- Home
- INFA vs HALO Comparison
INFA vs HALO Comparison
Compare INFA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFA
- HALO
- Stock Information
- Founded
- INFA 1993
- HALO 1998
- Country
- INFA United States
- HALO United States
- Employees
- INFA N/A
- HALO N/A
- Industry
- INFA EDP Services
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INFA Technology
- HALO Health Care
- Exchange
- INFA Nasdaq
- HALO Nasdaq
- Market Cap
- INFA 7.6B
- HALO 7.6B
- IPO Year
- INFA 2021
- HALO N/A
- Fundamental
- Price
- INFA $24.85
- HALO $68.24
- Analyst Decision
- INFA Hold
- HALO Buy
- Analyst Count
- INFA 12
- HALO 11
- Target Price
- INFA $23.91
- HALO $74.91
- AVG Volume (30 Days)
- INFA 1.3M
- HALO 2.2M
- Earning Date
- INFA 11-05-2025
- HALO 11-03-2025
- Dividend Yield
- INFA N/A
- HALO N/A
- EPS Growth
- INFA N/A
- HALO 56.68
- EPS
- INFA 0.03
- HALO 4.74
- Revenue
- INFA $1,678,707,000.00
- HALO $1,242,852,000.00
- Revenue This Year
- INFA $5.43
- HALO $32.47
- Revenue Next Year
- INFA $4.92
- HALO $24.31
- P/E Ratio
- INFA $733.48
- HALO $14.41
- Revenue Growth
- INFA 1.32
- HALO 31.19
- 52 Week Low
- INFA $15.65
- HALO $42.01
- 52 Week High
- INFA $27.88
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- INFA 49.69
- HALO 56.09
- Support Level
- INFA $24.82
- HALO $67.40
- Resistance Level
- INFA $24.89
- HALO $66.97
- Average True Range (ATR)
- INFA 0.03
- HALO 2.04
- MACD
- INFA -0.00
- HALO 0.51
- Stochastic Oscillator
- INFA 37.50
- HALO 71.78
About INFA Informatica Inc.
Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.